The audio version of this article is generated by AI-based technology. Mispronunciations can occur. We are working with our partners to continually review and improve the results. The closure of the ...

From reproductive rights to climate change to Big Tech, The Independent is on the ground when the story is developing. Whether it's investigating the financials of Elon Musk's pro-Trump PAC or ...

From reproductive rights to climate change to Big Tech, The Independent is on the ground when the story is developing. Whether it's investigating the financials of Elon Musk's pro-Trump PAC or ...

Add Yahoo as a preferred source to see more of our stories on Google. The Ajax was seen in its first public running display at Tankfest 2024 at The Tank Museum in Dorset, but problems quickly emerged ...

Add Yahoo as a preferred source to see more of our stories on Google. MPs have questioned whether the Army’s troubled £6.3 billion Ajax armoured vehicle will ever be fit for use in combat. The project ...

With all 34 rounds and play-offs in the books, the 2025-26 Eredivisie season has officially come to an end. How did all 18 teams fare, what went well for them, and what needs improving? Flashscore ...

Imagine a creature so evolutionarily resilient that it strolled right alongside the Tyrannosaurus Rex 350 million years ago, survived the asteroid impact, and now comfortably rents a space under your ...

Trials of the British Army’s Ajax armoured vehicles are set to resume, despite major delays amid concern for soldiers’ safety. Minister for Defence Readiness and Industry Luke Pollard announced in ...

Eli Lilly (LLY) has agreed to acquire biopharmaceutical company Ajax Therapeutics for up to $2.3B in cash, inclusive of an upfront payment and subsequent payments upon the achievement of certain ...

Eli Lilly said on Monday it would buy privately held cancer drug developer Ajax Therapeutics for up to $2.3 billion in cash, as the U.S. drugmaker looks to expand its oncology pipeline. Lilly has been ...

April 27 (Reuters) - Eli Lilly (LLY.N), opens new tab said on Monday it would buy privately held cancer drug developer Ajax Therapeutics for up ‌to $2.3 billion in cash, as the U.S. drugmaker looks to ...

Eli Lilly & Co. agreed to buy closely held Ajax Therapeutics Inc. for as much as $2.3 billion in cash, part of its effort to build out a portfolio of breakthrough cancer therapies. Ajax’s lead ...